Vitiligo is a condition that causes areas of skin to lose color, which is known as depigmentation. There are no ways to prevent vitiligo from developing, but treatment can help prevent it affecting ...

Pfizer (NYSE:PFE) reported positive Phase 3 results for LITFULO in nonsegmental vitiligo. The company plans to pursue global ...

July 30 (Reuters) - Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of ...

AbbVie on Wednesday said the European Commission approvals cover Rinvoq for the treatment of people ages 12 an older with severe alopecia areata, which causes a range of hair loss patterns, and with ...

Topline results from two Phase III clinical trials indicate that ritlecitinib demonstrated promising efficacy in patients ...

Pfizer has announced positive topline results from two phase 3 trials evaluating the efficacy and safety of Litfulo once ...

AbbVie (NYSE:ABBV) received European Commission approval for RINVOQ (upadacitinib) as the first systemic treatment in the EU ...

Hearing graduate student Bryson Southard talk, you’d never believe that he was ever anything but a confident, positive person. But the truth is, he has navigated a long road to get to this point.

The once-daily, oral TEC/JAK3 inhibitor has shown efficacy in active and stable nonsegmental vitiligo (NSV) – the most common form of the disease – in which the most common form of vitiligo, ...

Vitiligo is often misunderstood as merely a cosmetic issue, but for millions worldwide—including over a million in India—it’s a deeply personal and emotional struggle. Characterised by the loss of ...

Add Yahoo as a preferred source to see more of our stories on Google. Few people have seen my mother without makeup. Foundation, liquid eye liner, the works. She always applied lipstick throughout the ...